MedTrace Logo

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

NCT07240077 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-11-20

No results posted yet for this study

Summary

A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia

Conditions

  • Bacteremia
  • Streptococcus Infection

Interventions

DRUG

Beta-lactam monotherapy

Normal saline placebo

DRUG

Beta-lactam plus levofloxacin combination therapy

IV Levofloxacin

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07240077 on ClinicalTrials.gov